advances and considerations in the treatment and management of hr , her2-, advanced breast cancer
Published 4 years ago • 78 plays • Length 4:45Download video MP4
Download video MP3
Similar videos
-
2:15
outlook for hr /her2- advanced breast cancer treatment
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
2:05
important considerations in the management of hr , her2-negative early breast cancer
-
7:44
treatment options for her2 breast cancer: a comprehensive guide
-
7:15
asco 2023 expert report in hr positive, her2 negative breast cancer by catherine harper-wynne
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
5:28
capitello-291: capivasertib fulvestrant for ai-resistant hr /her2- advanced breast cancer
-
2:14
management of premenopausal hr /her2- breast cancer with micro-metastasis
-
30:49
conceptualizing guidelines to manage patients with hr–positive, her2-negative early breast cancer
-
29:21
new advances and opportunities for improvement in hr /her2- early breast cancer
-
1:55
advances in treatments for her2-positive metastatic breast cancer
-
22:12
how to treat her2 breast cancer in 2024 with dr. harold burstein
-
46:00
advanced breast cancer: challenges in pathways development
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
2:24
identifying drivers of first-line hr /her2- metastatic breast cancer treatment choices
-
5:14
adding alpelisib for hr /her2- advanced breast cancer in solar-1: adverse event impacts
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
0:34
helping to address unmet needs in metastatic hr /her2- breast cancer
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal